Allogeneic cell therapy using tissue source from healthy donor. Our allogeneic UCMSC's sourced tissue is derived from healthy donor, selected and qualified according to FDA standard and guidance. Manufacturing process is conducted in facilities with GMP (BPOM) certification. Cell bank is fully characterized according to international standard and stored in cryopreserved state.

Autologous cell therapy involves using a patient's own cells for therapeutic purposes. We developed Mesenchymal Stem Cell (MSC) from bone marrow, adipose tissue and umbilical cord tissue banking; peripheral blood mesenhymal stem cell (PBMNC) and EPC (Endothelial Progenitor Cell). PBMNC is heterogeneous population of mononuclear cells, derived from patient's own peripheral blood.EPC is also derived from patient's own peripheral blood. EPC have capability to differentatiate into blood vessel lining repair and regeneration and currently being developed for treatment of cardiovascular disease.

Secretome is a set of bioactive molecules and signalling factor secreted by stem cells. Secretome contains various type of protein, peptides, growth factors, cytokine, chemokine and extracellular vesicles. Secretome functions through "paracrine effect" or signalling, and play crucial role in cell to cell communication. They are potential as regenerative medicine agent, inducing tissue repair, immune modulation and anti-inflammation.